Amino acid combination with vitamins, minerals and trace elements for the curative and rehabilitative treatment of post-COVID syndrome, post-COVID-19 syndrome and post-vaccine syndrome.
Amino acid and nutrient combination stimulates cellular regeneration, addressing the unclear long-term symptoms of post-COVID and post-vaccine syndromes by enhancing the pituitary-gonadal system, effectively reducing symptoms and improving care levels.
Patent Information
- Application Number
- DE102023001399
- Authority / Receiving Office
- DE · DE
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2023-04-08
- Publication Date
- 2024-12-24
- Estimated Expiration
- 2043-04-08
AI Technical Summary
The long-term pathological symptoms of post-COVID syndrome, post-COVID-19 syndrome, and post-vaccine syndrome, such as chronic fatigue, neurological disorders, and organ dysfunction, are not clearly understood and lack a specific diagnosis due to excessive cell death and disrupted cellular regeneration, particularly from SARS-CoV-2 RNA reproduction and vaccine effects.
A combination of amino acids (arginine, ornithine, lysine, glycine) with vitamins (A, D3, E, C, B1, B2, B6, B12, folic acid, biotin, pantothenic acid) and minerals (calcium, potassium, zinc, copper, iodine, selenium, magnesium) is administered in a specific ratio and dosage to stimulate the pituitary-gonadal system, enhancing cellular regeneration and hormone production.
The combination significantly improves cellular regeneration, reducing symptoms and improving care levels in participants over six months, with no recurrence of symptoms after supplementation cessation.
Smart Images

Figure 00000000_0000_ABST
Abstract
Description
[0001] 1. Amino acid combination with vitamins, minerals and trace elements for the curative and rehabilitative treatment of post-COVID syndrome, post-COVID-19 syndrome and post-vaccine syndrome
[0002] 2. COVID-19, caused by the SARS-CoV-2 pathogen, usually results in a short-term course with mild to moderate symptoms such as fever, cough, runny nose, headache, body aches, and sore throat. Disturbances of the sense of smell and / or taste are possible.
[0003] However, pneumonia with shortness of breath and difficulty breathing can also develop.
[0004] The course of the disease is sometimes nonspecific, diverse, and varies greatly. Therefore, no general statements can be made about the "typical" course of the disease.
[0005] An infection can remain without any symptoms, but can also have severe courses and lead to death.
[0006] After a COVID-19 infection, some patients experience long-term consequences with pathological symptoms such as fatigue (chronic fatigue syndrome), POTS (postural tachycardia syndrome), impaired consciousness, neurological disorders, depression, cognitive deficits, shortness of breath, thrombosis, muscle atrophy, and long-term functional limitations of the peripheral vascular system.
[0007] These symptoms are referred to as post-COVID syndrome if the symptoms persist for more than 4 weeks and / or new symptoms occur.
[0008] These symptoms are referred to as post-COVID-19 syndrome if the symptoms persist for more than 12 weeks or if new symptoms / health disorders occur that cannot be explained.
[0009] These symptoms are referred to as post-vaccine syndrome when they occur after a Covid-19 vaccination.
[0010] In addition, post-vaccine syndrome is sometimes diagnosed with myocarditis, blood pressure fluctuations, visual disturbances and skin changes.
[0011] 3. The problem is that, according to current scientific knowledge, no clear cause has been found for the long-term pathological consequences of post-COVID syndrome, post-COVID-19 syndrome, or post-vaccine syndrome.
[0012] The multitude of pathological symptoms, some of which occur simultaneously, but also chronologically vary and occur additionally, makes a clear diagnosis impossible to date.
[0013] 4. In my evaluation of medical diagnostic tests, I noticed that all pathological symptoms have a common cause.
[0014] The cause is excessive death of tissue cells.
[0015] The CK values (sum of all creatine kinases in the body) found were almost exclusively strongly to extremely elevated, with values of up to 5,477 U / I.
[0016] The normal value for adult men is < 171 U / I and for adult women < 145 u / I.
[0017] Creatine kinase (CK) is an enzyme found in all muscle cells, organs of the body and the brain.
[0018] Elevated values indicate damage to the corresponding cells due to overload, injury and poisoning, as excessive cell death occurs.
[0019] At the same time, increased levels of uric acid were detected, since the nucleic acid contained in body cells is converted into uric acid during the breakdown of body cells.
[0020] Elevated levels of amino acids in the blood indicate a disorder in the protein pool.
[0021] Dietary proteins are broken down into amino acids in the digestive tract, which are then made available to the protein pool for storage. Almost all body cells function as protein pools, but primarily liver cells and skeletal muscle cells.
[0022] The amino acids required by the organism are then made available from this protein pool.
[0023] Since amino acids are stored and not proteins, the correct term would actually be amino acid pool.
[0024] If there is a significant increase in cell death, the amino acids supplied with food cannot be stored and are therefore present in increased concentrations in the blood.
[0025] What was striking was that the structurally simplest and most abundant amino acid, glycine, was not present in increased levels in the blood, but on the contrary, its concentration was far too low.
[0026] A further indication was that post-COVID syndrome, post-COVID-19 syndrome and post-vaccine syndrome could not be specifically defined by the age or gender of those affected, and there were clearly no pre-existing medical conditions.
[0027] Because the SARS-CoV-2 pathogen reprograms the body cells to produce its own RNA after infecting them, the body cells produce SARS-CoV-2 RNA at an unparalleled rate until the cell collapses and dies.
[0028] The SARS-CoV-2 RNA, now produced in incomparably large quantities, infects other cells, and these also continue to produce SARS-CoV-2 RNA at high speed until they too collapse and die.
[0029] This is where the real danger of the SARS-CoV-2 pathogen comes from: its incomparably high reproduction rate.
[0030] The same process occurs with COVID-19 vaccines.
[0031] In almost all healthy body cells, the formation of progenitor cells takes place, so-called precursor cells which then develop into the respective cell type.
[0032] The formation of progenitor cells is the basis of the entire regeneration of the human organism.
[0033] If a significant number of body cells are busy reproducing SARS-CoV-2 RNA and have even already died, sufficient progenitor cells can no longer be formed and regeneration no longer takes place.
[0034] This affects not only muscle cells, but also organ cells (all organs are also muscles), brain cells, nerve cells, gland cells, etc.
[0035] If brain cells are not regenerated sufficiently, this can lead to impaired consciousness, neurological disorders, depression, cognitive deficits, etc.
[0036] If sufficient liver cells are not regenerated, blood clotting disorders occur because the clotting factors are produced in the liver.
[0037] If muscle cells are not regenerated sufficiently, muscle atrophy occurs.
[0038] If blood cells are not regenerated sufficiently, anemia and thus fatigue (chronic fatigue syndrome) occur. A loss of blood volume cannot be measured quantitatively.
[0039] This can explain all pathological symptoms.
[0040] For increased regeneration, growth hormones and growth factors from the pituitary-gonadal system are necessary.
[0041] By stimulating the pituitary-gonadal system, the production of the growth hormone HGH (somatropin) and the growth hormone factor IGF 1 (insulin-like growth factors) is particularly stimulated.
[0042] HGH and IGF 1 are, among other things, the basic hormones for cellular regeneration and are therefore essential for regeneration.
[0043] I achieved stimulation of the pituitary-gonadal system with a combination of the amino acids arginine, ornithine, and lysine. The ratio is crucial here.
[0044] The amino acid glycine is the structurally simplest amino acid, but also the basic building block of all body cells (glycine was almost certainly the first amino acid on earth).
[0045] As previously mentioned, a disruption in the protein pool results in amino acids being present in the blood. However, the individual amino acids and their concentrations are important.
[0046] Individual amino acids and amino acid combinations have a corresponding influence on the metabolic state and, as a result, on the formation of hormones and enzymes.
[0047] Furthermore, vitamins, minerals and trace elements are necessary for regeneration.
[0048] It was necessary to find a mixture ratio in which the amino acids, vitamins, minerals and trace elements complement each other optimally.
[0049] Likewise, the correct dosage had to be found for an optimal intake regimen.
[0050] In order to combine optimal mechanisms of action, the following mixing ratio of powdered active ingredients per 100g of finished mixture was used: Arginine 6,049g Ornithine 6,049g Lysine 6,049g Glycine 75,607g Vitamin A 0.83331mg Vitamin D3 0.00521mg Vitamin E 9.38000mg Vitamin C 83.13000mg Vitamin B1 1,15000mg Vitamin B2 1.46000mg Niacin (B3) 16.66000mg Vitamin B6 1.46000mg Folic acid (B9) 0.20831mg Vitamin B12 0.00261mg Biotin 0.05210mg Pantothenic acid 6.25000mg Calcium 208.31000mg potassium 833.31000mg zinc 0.94000mg copper 1.04000mg iodine 0.15625mg selenium 0.05725mg magnesium 260,38000mg Maltodextrin 4.821g (carrier material) Dosage:
[0051] For every 10kg of body weight, 6.5g of ready-mixed product daily. Preparation:
[0052] Dissolve the ready-made mixture in 200ml of water and drink. Application:
[0053] Take 15g of the ready-mixed product directly before going to bed and the remaining amount spread throughout the day, preferably 20 minutes before meals, in 10g portions. Example: Person with 85kg body weight 8.5 × 6.5g = 55.25g rounded off 55g ready mix per day 10g before breakfast 10g before lunch 10g in the afternoon 10g before the evening meal 15g before going to bed experimental group 161 participants in total 21 participants with long COVID-19 syndrome without vaccination 58 participants Long COVID-19 syndrome with vaccination 39 participants post-vaccine syndrome without COVID-19 infection 43 participants Post-Vaccine Syndrome with COVID-19 infection
[0054] Due to the many different and varying symptoms, the participants were classified according to the care level in accordance with the assessment guidelines for determining the need for care in accordance with SGB XI. Care level I 13 participants Care level II 39 participants Care level III 102 participants Care level IV 7 participants Care level V 0 participants
[0055] The trial was conducted over a period of 6 months, with the level of care being assessed at the beginning of each month. time Average care rate change Test start 2,64 1 month 2,46 -0,18 2nd month 2,26 -0,20 3rd month 2,04 -0,22 4th month 1,80 -0,24 5th month 1,53 -0,27 6th month 1,22 -0,31
[0056] The experiment clearly shows that the organism's regeneration behavior becomes increasingly more intense.
[0057] Classification of participants according to care level at the end of the trial after 6 months. Care level I 52 participants Care level II 61 participants Care level III 7 participants Care level IV 0 participants Care level V 0 participants
[0058] 41 participants could no longer be assigned a care level.
[0059] All participants improved by at least one level of care.
[0060] After a further 2 months without supplementing the ready-made mixture, none of the participants experienced a recurrence of their previously subsided symptoms, nor did any existing symptoms worsen or new symptoms develop.
[0061] All individual components, including the combination and dosage, are classified as food supplements.
[0062] The individual components of the recipe and also the combination are completely free of negative side effects.
Claims
[1] Amino acid combination with vitamins, minerals and trace elements for the curative and rehabilitative treatment of post-COVID syndrome, post-COVID-19 syndrome and post-vaccine syndrome, characterized by the following amino acid combination with vitamins, minerals, and trace elements; in the ratio of powdered active ingredients per 100g of finished mixture: Arginine 6,049g Ornithine 6,049g Lysine 6,049g Glycine 75,607g Vitamin A 0.83331mg Vitamin D3 0.00521mg Vitamin E 9.38000mg Vitamin C 83.13000mg Vitamin B1 1,15000mg Vitamin B2 1.46000mg Niacin (B3) 16.66000mg Vitamin B6 1.46000mg Folic acid (B9) 0.20831mg Vitamin B12 0.00261mg Biotin 0.05210mg Pantothenic acid 6.25000mg Calcium 208.31000mg potassium 833.31000mg zinc 0.94000mg copper 1.04000mg iodine 0.15625mg selenium 0.05725mg magnesium 260,38000mg Maltodextrin 4.821g (carrier material) for use as a medicinal product in post-COVID syndrome without vaccine [2] Amino acid combination with vitamins and trace elements according to claim 1 for use as a medicament in post-COVID syndrome with vaccine vaccination [3] Amino acid combination with vitamins and trace elements according to claim 1 for use as a medicament in post-COVID-19 syndrome without vaccine vaccination [4] Amino acid combination with vitamins and trace elements according to claim 1 for use as a medicament in post-COVID-19 syndrome with vaccine vaccination [5] Amino acid combination with vitamins and trace elements according to claim 1 for use as a medicament in post-vaccine syndrome without COVID-19 infection [6] Amino acid combination with vitamins and trace elements according to claim 1 for use as a medicament in post-vaccine syndrome with COVID-19 infection [7] Amino acid combination with vitamins and trace elements according to claim 1 for use as a food supplement in post-COVID syndrome without vaccine vaccination [8] Amino acid combination with vitamins and trace elements according to claim 1 for use as a food supplement in post-COVID syndrome with vaccine vaccination [9] Amino acid combination with vitamins and trace elements according to claim 1 for use as a food supplement in post-COVID-19 syndrome without vaccine vaccination [10] Amino acid combination with vitamins and trace elements according to claim 1 for use as a food supplement in post-COVID-19 syndrome with vaccine vaccination [11] Amino acid combination with vitamins and trace elements according to claim 1 for use as a food supplement in post-vaccine syndrome without COVID-19 infection [12] Amino acid combination with vitamins and trace elements according to claim 1 for use as a food supplement in post-vaccine syndrome with COVID-19 infection
Citation Information
Patent Citations
A pharmaceutical combination preparation containing glycyrrhizic acid, zinc and a compound containing a thiol group or a group that can be metabolized to this
DE10340845A1
MEDICAL FOOD FOR SUPPLEMENTARY FOOD FOR CHILDREN / ADULTS WITH METABOLIC DISEASES
DE69330885T2
Dietetic multi-component system
WO2013006982A1
